» Articles » PMID: 9552408

Protein Kinase CK2 ("casein Kinase-2") and Its Implication in Cell Division and Proliferation

Overview
Specialty Cell Biology
Date 1997 Jan 1
PMID 9552408
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase CK2 (also termed casein kinase-2 or -II) is a ubiquitous Ser/Thr-specific protein kinase required for viability and for cell cycle progression. CK2 is especially elevated in proliferating tissues, either normal or transformed, and the expression of its catalytic subunit in transgenic mice is causative of lymphomas. CK2 is highly pleiotropic: more than 160 proteins phosphorylated by it at sites specified by multiple acidic residues are known. Despite its heterotetrameric structure generally composed by two catalytic (alpha and/or alpha') and two non catalytic beta-subunits, the regulation of CK2 is still enigmatic. A number of functional features of the beta-subunit which could cooperate to the modulation of CK2 targeting/activity will be discussed.

Citing Articles

Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.

Moon D Int J Mol Sci. 2024; 25(5).

PMID: 38474160 PMC: 10932100. DOI: 10.3390/ijms25052911.


GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Park A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B Nat Immunol. 2024; 25(2):282-293.

PMID: 38172257 PMC: 11151279. DOI: 10.1038/s41590-023-01691-y.


Protein Kinase CK2α', More than a Backup of CK2α.

Montenarh M, Gotz C Cells. 2023; 12(24).

PMID: 38132153 PMC: 10741536. DOI: 10.3390/cells12242834.


Site-specific phosphorylation of ZYG-1 regulates ZYG-1 stability and centrosome number.

Medley J, Yim R, DiPanni J, Sebou B, Shaffou B, Cramer E iScience. 2023; 26(12):108410.

PMID: 38034351 PMC: 10687292. DOI: 10.1016/j.isci.2023.108410.


Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26/DPP4 on colorectal carcinoma cells.

Fux J, Lefort E, Rao P, Blay J Front Pharmacol. 2023; 13:1086894.

PMID: 36618939 PMC: 9815539. DOI: 10.3389/fphar.2022.1086894.